Skip to content

Clinical trials

Waldenstrom Macroglobulinemia trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Country / region: Canada Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20041
20073
20081
20101
20111
20121
20132
20141
20151
20213
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting4
Recruiting4
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NCIC Clinical Trials Group5
Jonsson Comprehensive Cancer Center3
BeOne Medicines2
Janssen Research & Development, LLC2
National Cancer Institute (NCI)2
AbbVie1
Alliance for Clinical Trials in Oncology1
British Columbia Cancer Agency1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia28
Leukemia, Lymphocytic, Chronic, B-Cell18
Lymphoma, Follicular16
Lymphoma, B-Cell, Marginal Zone15
Lymphoma, Mantle-Cell15
Lymphoma14
Lymphoma, Large B-Cell, Diffuse13
Lymphoma, Non-Hodgkin13
Burkitt Lymphoma9
Precursor Cell Lymphoblastic Leukemia-Lymphoma9

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.